azacitidine has been researched along with Blepharitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aparicio, SA; Carlton, M; Colledge, B; de Algara, TR; Dixon, J; Heuser, M; Humphries, RK; Leung, M; McKinney, S; Tafech, A; Thresher, R; Yap, DB | 1 |
1 other study(ies) available for azacitidine and Blepharitis
Article | Year |
---|---|
Loss of MLL5 results in pleiotropic hematopoietic defects, reduced neutrophil immune function, and extreme sensitivity to DNA demethylation.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Bacterial Infections; Blepharitis; Cell Differentiation; Decitabine; DNA Methylation; Genotype; Hematopoiesis; Hematopoietic Stem Cells; Histone-Lysine N-Methyltransferase; Homozygote; Mice; Mice, Knockout; Myeloid-Lymphoid Leukemia Protein; Neutrophils | 2009 |